Study on efficacy and safety of dasatinib 50 mg in newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase (CP): Experience from a tertiary care hospital
Banarjee A et al. Indian J Hematol Blood Transfus, July 2026
Link to full abstract